Entera Bio Ltd.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Jerusalem
ENTX chart
What traders are saying about $ENTX
Latest postsEntera Bio Ltd. news
- Entera Bio Ltd. Announces Board and Board Committee Changes
marketscreener.com ·
- Entera Bio appoints Juan Arjona Ferreira to board of directors
Investing.com ·
- Form 8K Entera Bio Ltd. For: 27 October By Investing.com
Investing.com Canada ·
- Entera Bio appoints Juan Camilo Arjona Ferreira to board as Haya Taitel steps down
TradingView ·
- Entera Appoints Global Research and Development Leader Dr. Juan Camilo Arjona Ferreira to Its Board of Directors
Yahoo Finance ·
- A women’s health leader with more than 20 years developing medicines joins Entera’s board Dec. 1.
Stock Titan ·
- Entera Bio Ltd. Estimates – NASDAQ:ENTX
TradingView ·
- Entera Bio Ltd. (ENTX) Ticks Higher to $3.02 as Buyers Defend Key Support - Dividend Growth Stocks
https://www.dars.gov.et/ ·
- Eloxx Pharmaceuticals Appoints Biopharmaceutical Industry Veteran Geno Germano to its Board of Directors
Yahoo Finance ·
- Entera Presents Markedly Enhanced Anabolic Effects of EB613 (First-in-Class Oral PTH(1-34) Tablet) in Postmenopausal Women with Osteoporosis at High Risk of Fracture and Showcases Phase 3 Design at ASBMR 2026 Annual Meeting
Yahoo Finance ·
- Entera Bio Announces Additional Presentation of EB613 Phase 3 Study Design at the ASBMR 2026 Annual Meeting
Yahoo Finance ·
- Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
Yahoo Finance ·
Entera Bio Ltd. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $42,000 | $181,000 | $0 | $134,000 |
| Net income | -$11.4M | -$9.5M | -$8.9M | -$13.1M |
| Diluted EPS | $0.25 | $0.25 | $0.31 | $0.45 |
| Total assets (year end) | $16.0M | $9.4M | $11.8M | $13.1M |
| Cash and equivalents (year end) | $7.1M | $8.7M | $11.0M | $12.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Entera Bio Ltd.
- Ticker
- ENTX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Jerusalem
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1638097
Frequently asked questions
What exchange is Entera Bio Ltd. listed on?
Entera Bio Ltd. trades on the Nasdaq under the ticker symbol ENTX.
What industry is Entera Bio Ltd. in?
Entera Bio Ltd. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Entera Bio Ltd. headquartered?
Entera Bio Ltd.'s business address on file with the SEC is in Jerusalem.
When does Entera Bio Ltd.'s fiscal year end?
Entera Bio Ltd.'s fiscal year ends on December 31.
How much revenue did Entera Bio Ltd. report?
Entera Bio Ltd. reported $42,000 in revenue for calendar year 2025, according to its SEC filings.